ETONEton Pharmaceuticals, Inc.

$49.96+168% 1Y

What is the market doing?

Mixed

No clear lean: rangebound and moderately shorted.

2 neutral, 1 without data
TrendRangeboundderived · Oct 23, 2026

Choppy, but holding above its 200-day average. Oversold (RSI 23). Price is +44% vs its 200-day average.

Short interest6.4% of sharesFINRA · Sep 30, 2026

Moderately shorted, settled Sep 30, 2026, a few days of normal trading to cover.

Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.

How ETON is trading

Eton Pharmaceuticals, Inc. is +168% over the past year while the S&P 500 is +16%: 152 points ahead of the market.

+168%

1-year return · S&P 500 +16%

vs 200-day average
+44%

vs 200-day average · a clear uptrend

RSI (14)
23

RSI (14) · oversold, sold harder than it has been bought

Below its 52-week high
22%

Below its 52-week high

Oct 21, 2024$4.29 – $64.38 · dashed line: 200-day averageOct 23, 2026
Details›
Last close2026-10-23
$49.96
1 monthS&P 500 −0.94%
−16%
1 yearS&P 500 +16%
+168%
5 yearsS&P 500 +86%
+859%
vs 50-day average$56.92
−12%
52-week high
$64.38
52-week low
$14.35
Annualised volatility
67%
Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
$8.7M
Calendar-year price return
YearReturn
2026 (year to date)+195%
2025+27%
2024+204%
2023+55%
2022−34%
2021−47%
2020+13%
2019+18%
Average return by calendar month, 2018–2026
MonthYearsPositiveAverage
Jan84 of 8+5.0%
Feb84 of 8+0.75%
Mar84 of 8+0.08%
Apr83 of 8+4.1%
May85 of 8+1.9%
Jun82 of 8−4.4%
Jul84 of 8+0.41%
Aug86 of 8+17%
Sep84 of 8+4.5%
Oct84 of 8+5.5%
Nov74 of 7+5.1%
Dec85 of 8+5.2%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.

Where the price stands

Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.

What it has returned

With dividends, year by year, month by month, and by calendar month on average.